Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Nelson M. Wolf is active.

Publication


Featured researches published by Nelson M. Wolf.


American Journal of Cardiology | 1983

Intracoronary thrombus in nontransmural myocardial infarction and in unstable angina pectoris

Jay B. Mandelkorn; Nelson M. Wolf; Surender Singh; Jay A. Shechter; Robert I. Kersh; David M. Rodgers; Mark B. Workman; Lamberto G. Bentivoglio; Steven M. Laporte; Steven G. Meister

Although intracoronary thrombus formation plays a major role in acute transmural myocardial infarction (MI), its occurrence in unstable angina (UA) and nontransmural MI has not clearly been established. To determine whether intracoronary thrombus does occur in these syndromes, coronary arteriography was performed before, during, and after intracoronary nitroglycerin and streptokinase infusion in 17 patients. None of the 8 patients with nontransmural MI and 1 of the 9 patients with UA responded to intracoronary nitroglycerin. Seven of 8 patients with nontransmural MI and 4 of 9 patients with UA responded to streptokinase infusion with opening of an occluded vessel, an increase in stenotic diameter, dissolution of an intracoronary filling defect, or a combination of these. Serial opening and closing of ischemia-related vessels occurred spontaneously and in response to streptokinase in some patients in whom thrombolysis was demonstrated. Evidence of thrombolysis was not seen in any patient studied longer than 1 week from the onset of the rest pain syndrome. The finding of thrombolysis in several patients with nontransmural MI and UA suggests that intracoronary thrombus formation plays a pathogenetic role in some patients with these ischemic syndromes.


American Journal of Cardiology | 1985

Frequency of intracoronary filling defects by angiography in Angina pectoris at rest

Gaetano Capone; Nelson M. Wolf; Benjamin Meyer; Steven G. Meister

Recent studies have shown that pain at rest in patients with unstable angina pectoris is often caused by transient reduction in regional myocardial perfusion. Coronary spasm has been implicated as a mechanism of this phenomenon. Recent reports have documented the occurrence of intracoronary thrombus in patients with unstable angina. Previous surveys have estimated a 6 to 12% frequency of intracoronary thrombus in this syndrome, but have not examined whether this incidence is related to how recent the angina at rest was. Angiograms of 119 patients with unstable angina who had rest pain within 14 days of angiography and 35 patients with stable angina were surveyed. Patients with unstable angina were subgrouped according to how recent angina at rest was at the time of angiography. Group I consisted of 44 patients in whom rest pain occurred within 24 hours before angiography. The 75 patients in group II had angina at rest between 1 and 14 days before angiography. Patients in group II had stable angina. The angiographic criterion for intracoronary thrombus was an intraluminal filling defect, surrounded by contrast medium on 3 sides, located just distal to or within a coronary stenosis, as assessed by each of 2 independent observers blinded to the nature of the anginal syndrome and its temporal proximity. Intracoronary thrombi were found in 44 of 119 patients with unstable angina (37%) and 0 of 35 patients with stable angina (p less than 0.00002). Intracoronary thrombi were found in 23 of 44 patients (52%) in group I and 21 of 75 (28%) in group II (p less than 0.008).(ABSTRACT TRUNCATED AT 250 WORDS)


Journal of the American College of Cardiology | 1987

Effect of calcium-binding additives on ventricular fibrillation and repolarization changes during coronary angiography.

L. Steven Zukerman; Ted Friehling; Nelson M. Wolf; Steven G. Meister; George Nahass; Peter R. Kowey

Ventricular fibrillation during coronary angiography with Renografin-76 (meglumine sodium diatrizoate) has been attributed to the calcium-binding additives sodium citrate and sodium ethylenediaminetetraacetic acid (EDTA), which may produce repolarization changes manifested as prolongation of the QT interval. Angiovist-370 is a newer form of meglumine sodium diatrizoate that contains calcium EDTA as its additive and thus has a decreased calcium-binding effect. Eight hundred sixteen patients were prospectively randomized to receive either Renografin-76 or Angiovist-370. Ventricular fibrillation occurred in 10 of 410 patients receiving Renografin-76 and in 0 of 406 patients given Angiovist-370 (p less than 0.0005). Clinical data were analyzed without knowledge of other data in the 10 patients treated with Renografin-76 who had ventricular fibrillation (Group I), 103 randomly selected patients who also received Renografin-76 but had no ventricular fibrillation (Group II) and 108 randomly selected patients given Angiovist-370 (Group III). Of several variables examined, only the QT interval differentiated patients receiving Renografin-76 and Angiovist-370. The mean corrected QT interval (QTc interval) before coronary angiography was slightly but not significantly (p = 0.7) higher in Group I than in Groups II and III. Ten seconds after the first left coronary artery injection it was more prolonged in Groups I and II (0.552 and 0.561 second, respectively) than in Group III (0.448 second) (p less than 0.00005). Similarly, 10 seconds after the first right coronary artery injection it was significantly longer in Groups I and II (0.545 and 0.544 second) than in Group III (0.477 second) (p less than 0.00005).(ABSTRACT TRUNCATED AT 250 WORDS)


Angiology | 2003

Right ventricular foreign body: percutaneous transvenous retrieval of a Greenfield filter from the right ventricle--a case report.

Heidar Arjomand; Satish Surabhi; Nelson M. Wolf

A 55-year-old man suffered head injury during a motor vehicle accident. He underwent a prophylactic inferior vena cava Greenfield filter placement. The filter migrated and lodged in the right ventricle at the level of the tricuspid valve. Successful percutaneous, transvenous retrieval of the Greenfield filter from the right ventricle was carried out.


Angiology | 2002

Association of Carotid Artery Intima-Media Thickness with Complex Aortic Atherosclerosis in Patients with Recent Stroke

Panayotis Fasseas; Emmanouil S. Brilakis; Biana Leybishkis; Marc Cohen; Alexis B. Sokil; Nelson M. Wolf; Rose Lee Dorn; Andrew B. Roberts; William Vandecker

This study was undertaken to determine whether carotid intima-media thickness can predict complex aortic atherosclerosis. A retrospective review was conducted of 64 consecutive patients who underwent transesophageal echocardiography and carotid ultrasonography for evaluation of recent ischemic stroke at MCP Hahnemann University, Medical College of Pennsylvania Hospital between January 1, 1999, and December 31, 1999. The mean age was 65 ± 14 years and 59% of the patients were women. Thirty-nine patients (61 %) had carotid atherosclerosis (defined as an intima-media thickness ≥ 1 mm) and seven patients (11%) had complex aortic atherosclerosis (defined as the presence of protruding atheroma ≥4 mm thick, mobile atherosclerotic debris, or plaque ulceration in any aortic segment by transesophageal echocardiography). Compared to patients without complex aortic atherosclerosis, patients with complex aortic atherosclerosis were more likely to have hypercholesterolemia (19% vs 57%, p = 0.05) and a carotid intima-media thickness of 2 mm or greater (35% vs 86%, p = 0.02). A carotid intima-media thickness of 2 mm or more had 86% sensitivity, 65% specificity, 23% positive predictive value, 97% negative predictive value, 2.5 positive likelihood ratio, and 0.22 negative likelihood ratio for the diagnosis of complex aortic atherosclerosis. Carotid intima- media thickness measurement can be used to noninvasively estimate the probability of complex aortic atherosclerosis. A carotid intima-media thickness less than 2 mm makes complex aortic atherosclerosis very unlikely.


American Journal of Cardiology | 1983

Frequency and importance of unprovoked coronary spasm in patients with angina pectoris undergoing percutaneous transluminal coronary angioplasty

Lamberto G. Bentivoglio; Louis R. Leo; Nelson M. Wolf; Steven G. Meister

Abstract Coronary spasm superimposed on fixed coronary artery stenosis was discovered in 14 of 74 candidates for percutaneous transluminal coronary angioplasty (PTCA). In 3 of the 14, spasm developed during PTCA and was presumably catheter-induced. Eleven of the 14, with unprovoked spasm, are the subject of this study. Three of the 11, in whom the fixed component of the mixed stenosis was subcritical were treated medically, with good results in 2 but with persistent angina pectoris and eventual myocardial infarct in 1. Nitroglycerin administered by the intracoronary route relieved spasm resistant to sublingual nitroglycerin in 1 of the 3. In 8 of the 11 with critical fixed stenosis, spasm was discovered either before PTCA (7 patients) or on follow-up (1 patient). Six of the 8 had successful PTCA, with no or mild symptoms on follow-up. Of the 2 failures, 1, uncomplicated, was followed by successful elective coronary artery bypass surgery while the other, complicated, led to successful emergency coronary artery bypass surgery, with disappearance of symptoms in both. The rate of success was similar in patients with documented unprovoked spasm (6 of 8) and patients without (39 of 63, 62%). It is concluded that (1) coronary spasm, if properly sought for, is probably not uncommon in single-vessel candidates for PTCA; (2) patients considered candidates for PTCA should have intracoronary nitroglycerin administered before PTCA; (3) in patients with critical, fixed coronary artery disease, associated spasm does not reduce the chances of successful PTCA; (4) coronary spasm may outlast the relief by PTCA of the fixed component of the mixed stenosis and requires long-term vasodilator therapy; and (5) the lack of adverse effects when PTCA is performed in patients with spasm superimposed on critical fixed single-vessel stenosis appears to justify its use for the time being.


Journal of Cardiovascular Electrophysiology | 1998

VENTRICULAR TACHYCARDIA : A LIFE-THREATENING ARRHYTHMIA IN A PATIENT WITH CONGENITALLY CORRECTED TRANSPOSITION OF THE GREAT ARTERIES

John M. Fontaine; Bindu M. Kamal; Alexis B. Sokil; Nelson M. Wolf

Congenitally Corrected Transposition and VT. Ventricular tachycardia (VT) is an uncommon finding in patients with congenitally corrected transposition of the great arteries (CCTGA). Cardiac death in patients with CCTGA has been attributed to complete heart block, systemic ventricular dysfunction, or severe AV valve regurgitation with heart failure. We descrihe the case of a patient who presented with palpitations and near‐syncope that was associated with clinical episodes of VT. Programmed ventricular stimulation revealed easily inducible sustained VT that immediately degenerated to ventricular fibrillation and subsequently required therapy with an implantable cardioverter defibrillator.


Journal of Cardiothoracic and Vascular Anesthesia | 1992

General anesthesia complicated by unexpected hypertension and tachycardia

David L. Reich; John L. Bucek; Nelson M. Wolf; David B. Klumpe; David J. Cullen

A 33-year-old, 63-kg man with systemic lupus erythematosus, mild diastolic hypertension, coronary artery disease (CAD), and severe mitral regurgitation (MR) was admitted for elective myocardial revascularization and mitral valve replacement. His chronic preoperative medications included prednisone, isosorbide dinitrate, enalapril, and furosemide. Physical examination was remarkable for a loud holosystolic murmur radiating to the axilla and stigmata of systemic lupus erythematosus. The patient received his usual medications on the morning of surgery, plus 100 mg of intravenous (IV) hydrocortisone. In addition to standard monitoring (electrocardigraphic [ECG] leads II and Vs, and digital pulse oximetry), invasive hemodynamic monitoring was established using local anesthesia, and included radial arterial and pulmonary artery catheters (PAC). Upon induction of anesthesia using fentanyl, 4,000 pg, midazolam, 2 mg, and metocurine, 20 mg, the heart rate (HR) rapidly increased from 80 to 140 beats/min, mean arterial pressure (MAP) increased from 90 to 135 mm Hg (Fig l), and mean pulmonary arterial pressure (PAP) increased from 27 to 53 mm Hg. A Berman-type oral airway was placed to facilitate mask ventilation, but controlled ventilation by mask was extremely difficult due to truncal rigidity. Upper extremity rigidity and cutaneous pallor were also noted. IV esmolol, 150 mg, labetalol, 20 mg, and nitroprusside, 40 ug, were administered during the next 1.5 minutes, and a nitroglycerin infusion (1.6 pg/kg/min) was begun. The MAP returned to an acceptable level in approximately 10 minutes. Pancuronium, 5 mg, was admin-


Archive | 1982

Dynamic Changes in Left Ventricular Geometry and Pressure During Coronary Artery Occlusion in Man

Lamberto G. Bentivoglio; Michael J. Barrett; Nelson M. Wolf; Steven G. Meister

Analysis of the early left ventricular geometry and hemodynamic response to the abrupt occlusion of a major coronary artery has not been feasible in man thus far.


Archive | 1985

Postoperative Management of Patients with Implanted Valvular Prostheses

Steven G. Meister; Nelson M. Wolf

Steady improvement in cardiac surgical techniques and prosthetic devices during the past two decades has made the postoperative management of valvular surgery patients enormously easier than it once was. Today, if patients are good surgical candidates, and if the procedure has gone smoothly, survival is the rule, and postoperative management is usually not critical. However, since patients are often not ideal candidates and surgery is not always perfect, skilled postoperative care can save lives that would otherwise be lost. In this chapter we will review the principles and techniques of postoperative management from the standpoint of the medical cardiologist. Since early postoperative management and long-term management typically involve somewhat different sets of problems they will be dealt with in separate sections.

Collaboration


Dive into the Nelson M. Wolf's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

David L. Reich

Icahn School of Medicine at Mount Sinai

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge